4//SEC Filing
Milne David Bruce 4
Accession 0001209191-22-016901
CIK 0000876378other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 8:00 AM ET
Size
18.4 KB
Accession
0001209191-22-016901
Insider Transaction Report
Form 4
Milne David Bruce
Director
Transactions
- Purchase
Common Stock
2022-03-07$0.61/sh+50,000$30,325→ 444,884 total - Purchase
Common Stock
2022-03-07$0.63/sh+69,232$43,595→ 619,884 total - Purchase
Common Stock
2022-03-04$0.63/sh+50,000$31,745→ 394,884 total - Purchase
Common Stock
2022-03-07$0.62/sh+100,000$61,550→ 544,884 total - Purchase
Common Stock
2022-03-04$0.64/sh+50,000$31,885→ 294,884 total - Purchase
Common Stock
2022-03-07$0.62/sh+5,768$3,571→ 550,652 total - Purchase
Common Stock
2022-03-04$0.64/sh+50,000$32,115→ 344,884 total
Footnotes (8)
- [F1]The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6305 to $0.64 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
- [F2]The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6385 to $0.6485 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
- [F3]The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6325 to $0.64 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
- [F4]The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6051 to $0.6136 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
- [F5]The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.61 to $0.6161 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
- [F6]The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6161 to $0.62 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
- [F7]The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6232 to $0.63 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
- [F8]The securities held following the reported transactions include 29,231 Restricted Stock Units granted on July 1, 2021. Forfeiture restrictions will lapse on such Restricted Stock Units on the first anniversary of the date of grant, or, if earlier, on the date of the Company's 2022 annual meeting of stockholders.
Documents
Issuer
ASENSUS SURGICAL, INC.
CIK 0000876378
Entity typeother
Related Parties
1- filerCIK 0001585207
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 8:00 AM ET
- Size
- 18.4 KB